Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,041 | 1,374 | 11,631 | 10,665 | 10,744 |
| Marketable Securities | N/A | 167 | 174 | 172 | 180 |
| Receivables | 11,587 | 11,695 | 2,294 | 3,380 | 3,369 |
| Inventories | 254 | 315 | N/A | N/A | N/A |
| TOTAL | $15,603 | $15,132 | $15,552 | $15,438 | $15,662 |
| Non-Current Assets | |||||
| PPE Net | 7,391 | 7,923 | 4,232 | 4,319 | 4,764 |
| Intangibles | N/A | N/A | 5,980 | N/A | N/A |
| Other Non-Current Assets | 19,865 | 19,458 | 2,872 | 8,952 | 8,749 |
| TOTAL | $27,257 | $27,381 | $13,084 | $13,272 | $13,513 |
| Total Assets | $42,860 | $42,513 | $28,636 | $28,709 | $29,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,630 | 4,671 | 3,692 | 3,879 | 3,079 |
| Other current liabilities | 2,598 | 2,385 | N/A | N/A | N/A |
| TOTAL | $7,228 | $7,056 | $3,692 | $3,879 | $3,079 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,847 | 8,942 | 0 | 0 | 127 |
| TOTAL | $9,262 | $9,513 | $476 | $N/A | $127 |
| Total Liabilities | $16,491 | $16,569 | $4,168 | $3,879 | $3,206 |
| Shareholders' Equity | |||||
| Retained earnings | -528 | -1,092 | -694 | -130 | -121 |
| Other shareholders' equity | -2,574 | 13 | 0 | 0 | 0 |
| TOTAL | $26,369 | $25,944 | $24,468 | $24,830 | $25,969 |
| Total Liabilities And Equity | $42,860 | $42,513 | $28,636 | $28,709 | $29,175 |